Navigating the Foreign Corrupt Practices Act for the Life Science Industry
10 December 2015
Past Event
Location
Web Conference
Partner David Simon will discuss the Foreign Corrupt Practices Act and its effect on the life sciences industry.
The webinar provides an in-depth overview of the significant risks involved when companies lack the management of compliance.
To watch a recording of the webinar, click here.
To watch a recording of the webinar, click here.
People
Related Services
Industry Teams
Practice Areas
Insights
Guess what? The SEC is regulating Crypto!
12 May 2021
Internet, IT & e-Discovery Blog
Bracing for the Next Wave of Health Care Enforcement
12 May 2021
Health Care Law Today
SEC Commissioner: What Do LIBOR Transition and ESG/SFDR Have In Common? – Each Might Make You a Werewolf!
11 May 2021
Foley Funds Legal Focus
Investment Adviser to Mutual Fund Cited for Undisclosed Conflicts
11 May 2021
Foley Funds Legal Focus
Hatcher Discusses her Practice in Of Counsel's May Issue
11 May 2021
Of Counsel
Foley Named a 2020 Top-Performing Lobbying Firm by Bloomberg Government
11 May 2021
Bloomberg Government
Kaplan Discusses How to Handle Employees Who May Be Faking COVID-19
10 May 2021
Legal Talk Network
Lehot Quoted in Law360 on SPAC Oversight
10 May 2021
Law360
Home Care 100
27-30 June 2021
Marco Island, FL
American Telemedicine Association ATA2021 Conference
June 2021
Virtual Conference
Health Care Fraud Enforcement Trends: New or Different Challenges Ahead?
17 June 2021
Webinar
2021 AANP National Conference
15 June - 31 August 2021
Virtual Conference
Navigating the Foreign Corrupt Practices Act for the Life Science Industry
Location
Web Conference